David Chang

www.advancedtherapies.com - China

Profile

Dr. Chang brings strong leadership and a wealth of experience in cell and gene therapy and biopharmaceutical technical development, manufacturing operations, engineering and strategy. Prior to joining WuXi AppTec, Dr. Chang was Corporate Vice President and Head of Cell Therapy Global Manufacturing at Celgene, a Bristol Myers Squibb company, where he oversaw the CAR-T manufacturing network and the global manufacturing sciences and technologies teams. He also served as the Global Head of Engineering and Strategy at Roche, Switzerland, after roles that included Vice President/Site Head of Roche Shanghai Technical Operations, China.

David has a wealth of experience in gene and cell therapy, and biopharmaceutical technical development, manufacturing operations, engineering and strategy. Formerly Corporate Vice President and Head of Cell Therapy Global Manufacturing in Celgene Corporation, a Bristol-Myers Squibb company. Ph.D. in biochemical engineering from Massachusetts Institute of Technology.